These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24715427)

  • 1. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
    Cytometry B Clin Cytom; 2015 Jan; 88(1):69-73. PubMed ID: 24715427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
    Cytometry B Clin Cytom; 2014 Mar; ():. PubMed ID: 24659135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell leukemia: a retrospective study of 10 cases.
    Agarwal AD; Brahmbhatt BS; Parikh BP; Shah MJ
    Indian J Cancer; 2014; 51(1):18-9. PubMed ID: 24947090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
    Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
    Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia.
    Kraj M; Kopeć-Szlęzak J; Pogłód R; Kruk B
    Leuk Res; 2011 Feb; 35(2):169-76. PubMed ID: 20553988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD138+ carcinocythemia mimicking plasma cell leukemia by flow cytometry.
    Barksdale B; Leith CP
    Blood; 2020 Oct; 136(14):1698. PubMed ID: 33002126
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
    Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cCD79a expression in a case of plasma cell leukemia.
    Alonso ML; Rubiol E; Mateu R; Estivill C; Bellido M; Balmaña J; Nomdedéu JF
    Leuk Res; 1998 Jul; 22(7):649-53. PubMed ID: 9680117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
    Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
    Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible expression of CD138 on mature follicular B cells is downregulated by IL-4.
    Lee JG; Moon H; Park C; Shin SH; Kang K; Kim TJ
    Immunol Lett; 2013; 156(1-2):38-45. PubMed ID: 24029663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrupt Development of Plasma Cell Leukemia in a Patient with Chronic Anemia under Follow-up.
    Farzaneh MR; Moradi A; Ravanbod MR; Daghbashi M
    Arch Iran Med; 2016 Jan; 19(1):75-7. PubMed ID: 26702753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
    Alghasham N; Alnounou R; Alzahrani H; Alsharif F
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell leukemia masquerading as ALL-L3--a case report.
    Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R
    Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
    Wu Y; Zhang X; Ma X; Suo X; Li R
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping of plasma cells.
    Rawstron AC
    Curr Protoc Cytom; 2006 May; Chapter 6():Unit6.23. PubMed ID: 18770841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma with CD138 changed from positive to negative: A case report.
    Yu J; Tan L; Wu Q; Rao Y; Ao J; Yang W; Zou B; Chen J
    Cytometry B Clin Cytom; 2021 Mar; 100(2):249-253. PubMed ID: 31967404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
    Kara IO; Duman BB; Afsar CU
    J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.